Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent for the outbreak of coronavirus disease 2019 (COVID-19). This global pandemic is now calling for efforts to develop more effective COVID-19 therapies. Here we use a host-directed approach, which focuses on cellular res...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Heliyon
Main Authors: Huang, Chen-Tsung, Chao, Tai-Ling, Kao, Han-Chieh, Pang, Yu-Hao, Lee, Wen-Hau, Hsieh, Chiao-Hui, Chang, Sui-Yuan, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7709728/
https://ncbi.nlm.nih.gov/pubmed/33289002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2020.e05646
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares